Ovarian Cancer Epidemiology, Healthcare Access and Disparities (ORCHiD): methodology for a population-based study of black, Hispanic and white patients with ovarian cancer

QR Code

Ovarian Cancer Epidemiology, Healthcare Access and Disparities (ORCHiD): methodology for a population-based study of black, Hispanic and white patients with ovarian cancer

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Bin Huang, Lauren Wilson, Maria Pisu, Tomi Akinyemiju, Andrew Berchuck, Ashwini Joshi, Kevin Ward, Margaret Liang, April Deveaux, Anjali Gupta, Malcolm Bevel, Chioma Omeogu, Onyinye Ohamadike, Molly McFatrich, Erin Daniell, Laura Jane Fish, Maria Schymura, Arnold L Potosky
Format:	article
Langue:	EN
Publié:	BMJ Publishing Group 2021
Sujets:	Medicine R
Accès en ligne:	https://doaj.org/article/b63e63f5ff3442149baec5529be067c4
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Bevacizumab in the treatment of ovarian cancer
par: Ramez N Eskander, et autres
Publié: (2011)

NMDA receptors are expressed in human ovarian cancer tissues and human ovarian cancer cell lines
par: North WG, et autres
Publié: (2015)

Familial Ovarian Cancer Clusters with Other Cancers
par: Guoqiao Zheng, et autres
Publié: (2018)

Connections between prolactin and ovarian cancer.
par: Amira Alkharusi, et autres
Publié: (2021)

Thoracic surgery for ovarian cancer recurrence
par: V.V. Boyko, et autres
Publié: (2017)

The anti-cancer effects of itraconazole in epithelial ovarian cancer
par: Chel Hun Choi, et autres
Publié: (2017)

Next steps in the early detection of ovarian cancer
par: Robert C. Bast, et autres
Publié: (2021)

The Development of Nanoparticles for the Detection and Imaging of Ovarian Cancers
par: Edward Henderson, et autres
Publié: (2021)

MicroRNA characteristics in epithelial ovarian cancer.
par: Kira Philipsen Prahm, et autres
Publié: (2021)

Bioenergetic Adaptations in Chemoresistant Ovarian Cancer Cells
par: Sajad Dar, et autres
Publié: (2017)

Ovarian cancer: emerging molecular-targeted therapies
par: Sourbier C
Publié: (2012)

The multicellular signalling network of ovarian cancer metastases
par: Leah Sommerfeld, et autres
Publié: (2021)

Peritoneal Modulators of Endometriosis-Associated Ovarian Cancer
par: Sarah Brunty, et autres
Publié: (2021)

Diagnostic measures comparison for ovarian malignancy risk in Epithelial ovarian cancer patients: a meta-analysis
par: Arpita Suri, et autres
Publié: (2021)

Expression of Cyclin D1 gene in ovarian cancer and effect of silencing its expression on ovarian cancer cells based on the Oncomine database
par: Li-Li Quan, et autres
Publié: (2021)

Functional implications of PABPC1 in the development of ovarian cancer
par: Feng Cong, et autres
Publié: (2021)

MICU1 drives glycolysis and chemoresistance in ovarian cancer
par: Prabir K. Chakraborty, et autres
Publié: (2017)

Amplification of USP13 drives ovarian cancer metabolism
par: Cecil Han, et autres
Publié: (2016)

Prognostic significance of tumor laterality in advanced ovarian cancer
par: Yuki Yamada, et autres
Publié: (2021)

Breast Carcinomatous Lymphangitis as an Unusual Presentation of Ovarian Cancer
par: Barbara Muoio, et autres
Publié: (2021)

An Assessment of Ovarian Cancer Histotypes Across the African Diaspora
par: Sophia H. L. George, et autres
Publié: (2021)

On the reproducibility of TCGA ovarian cancer microRNA profiles.
par: Ying-Wooi Wan, et autres
Publié: (2014)

Ovarian cancer and body size: individual participant meta-analysis including 25,157 women with ovarian cancer from 47 epidemiological studies.
par: Collaborative Group on Epidemiological Studies of Ovarian Cancer
Publié: (2012)

The clinical and pathological characteristics and survival of patients with advanced ovarian cancer
par: Popović Miroslav, et autres
Publié: (2021)

PAX8 and MECOM are interaction partners driving ovarian cancer
par: Melusine Bleu, et autres
Publié: (2021)

Integrated extracellular microRNA profiling for ovarian cancer screening
par: Akira Yokoi, et autres
Publié: (2018)

Clinical utility of targeted treatments in the management of epithelial ovarian cancer
par: Twu C, et autres
Publié: (2012)

BRCAness profile of sporadic ovarian cancer predicts disease recurrence.
par: Weiya Z Wysham, et autres
Publié: (2012)

Mesothelial-to-Mesenchymal Transition and Exosomes in Peritoneal Metastasis of Ovarian Cancer
par: Lucía Pascual-Antón, et autres
Publié: (2021)

Selection and Characterization of Vimentin-Binding Aptamer Motifs for Ovarian Cancer
par: Andrea M. Costello, et autres
Publié: (2021)

The Protein Landscape of Mucinous Ovarian Cancer: Towards a Theranostic
par: Arkan Youssef, et autres
Publié: (2021)

Prediction of Key Candidate Genes for Platinum Resistance in Ovarian Cancer
par: Guo K, et autres
Publié: (2021)

Epiphycan Predicts Poor Outcomes and Promotes Metastasis in Ovarian Cancer
par: Lu Deng, et autres
Publié: (2021)

Lentinan Combined with (125)I Brachytherapy for Recurrent Ovarian Cancer
par: Qin Jiang, et autres
Publié: (2021)

Spermatogenesis associated retrogenes are expressed in the human ovary and ovarian cancers.
par: Jan Rohozinski, et autres
Publié: (2009)

Survival-related profile, pathways, and transcription factors in ovarian cancer.
par: Anne P G Crijns, et autres
Publié: (2009)

Absence of BRCA/FMR1 correlations in women with ovarian cancers.
par: Norbert Gleicher, et autres
Publié: (2014)

RNA m6A methylation regulators in ovarian cancer
par: Jialu Guo, et autres
Publié: (2021)

Recurrence monitoring for ovarian cancer using a cell phone-integrated paper device to measure the ovarian cancer biomarker HE4/CRE ratio in urine
par: Emily C. Kight, et autres
Publié: (2021)

Retraction to ‘DDP-resistant ovarian cancer cells-derived exosomal microRNA-30a-5p reduces the resistance of ovarian cancer cells to DDP’
par: Ronghua Liu, et autres
Publié: (2021)